Nkarta (NKTX) Accumulated Expenses (2019 - 2026)
Nkarta (NKTX) posted quarterly Accumulated Expenses of $9.5 million for Q1 2026, down 15.69% year-over-year from $11.3 million in Q1 2025, and down 28.21% quarter-over-quarter from $13.3 million in Q4 2025.
Nkarta (NKTX) Accumulated Expenses (2019 - 2026) Analysis & Trends
Nkarta's Accumulated Expenses history runs 8 years deep, the most recent figure standing at $9.5 million for Q1 2026.
- In Q1 2026, Accumulated Expenses fell 15.69% year-over-year to $9.5 million; the TTM figure through Mar 2026 stood at $9.5 million (down 15.69% YoY), while the FY2025 annual figure was $13.3 million, up 8.66% from the prior year.
- Accumulated Expenses for Q1 2026 stood at $9.5 million, down from $13.3 million in the prior quarter.
- The five-year high for Accumulated Expenses was $17.6 million in Q2 2023, with the low at $6.3 million in Q1 2022.
- The 5-year median for Accumulated Expenses is $12.2 million (2024), against an average of $12.3 million.
- The sharpest annual moves came in 2023 and 2024: Accumulated Expenses surged 145.67% in 2023, then sank 34.11% in 2024.
- Nkarta's Accumulated Expenses stood at $16.0 million in 2022, then declined by 15.22% to $13.6 million in 2023, then declined by 10.05% to $12.2 million in 2024, then gained by 8.66% to $13.3 million in 2025, then declined by 28.21% to $9.5 million in 2026.
- Business Quant data shows NKTX's Accumulated Expenses at $9.5 million in Q1 2026, $13.3 million in Q4 2025, and $11.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Nkarta | 201.14 Mn | 201.14 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 12.46 Mn |
| Mar 31, 2026 | 9.54 Mn |
| Dec 31, 2025 | 13.29 Mn |
| Sep 30, 2025 | 11.18 Mn |
| Jun 30, 2025 | 10.51 Mn |
| Mar 31, 2025 | 11.32 Mn |
| Dec 31, 2024 | 12.23 Mn |
| Sep 30, 2024 | 13.78 Mn |
| Jun 30, 2024 | 11.57 Mn |
| Mar 31, 2024 | 12.93 Mn |
| Dec 31, 2023 | 13.60 Mn |
| Sep 30, 2023 | 15.30 Mn |
| Jun 30, 2023 | 17.55 Mn |
| Mar 31, 2023 | 14.82 Mn |
| Dec 31, 2022 | 16.04 Mn |
| Sep 30, 2022 | 11.57 Mn |
| Jun 30, 2022 | 7.15 Mn |
| Mar 31, 2022 | 6.32 Mn |
| Dec 31, 2021 | 9.35 Mn |
| Sep 30, 2021 | 7.45 Mn |